Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL (2020)
Rodriguez, Sonia; Abundis, Christina; Boccalatte, Francesco; Mehrotra, Purvi; Chiang, Mark Y.; Yui, Mary A.; Wang, Lin; Zhang, Huajia; Zollman, Amy; Bonfim-Silva, Ricardo 
; Kloetgen, Andreas; Palmer, Joycelynne; Sandusky, George; Wunderlich, Mark; Kaplan, Mark H.; Mulloy, James C.; Marcucci, Guido; Aifantis, Iannis; Cardoso, Angelo A.; Carlesso, Nadia
Source: Leukemia. Unidade: FMRP
Subjects: APOPTOSE, REGULAÇÃO GÊNICA, LEUCEMIA, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Sonia et al. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia, v. 34, n. 5, p. 1241-1252, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41375-019-0653-z. Acesso em: 10 nov. 2024.APA
Rodriguez, S., Abundis, C., Boccalatte, F., Mehrotra, P., Chiang, M. Y., Yui, M. A., et al. (2020). Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia, 34( 5), 1241-1252. doi:10.1038/s41375-019-0653-zNLM
Rodriguez S, Abundis C, Boccalatte F, Mehrotra P, Chiang MY, Yui MA, Wang L, Zhang H, Zollman A, Bonfim-Silva R, Kloetgen A, Palmer J, Sandusky G, Wunderlich M, Kaplan MH, Mulloy JC, Marcucci G, Aifantis I, Cardoso AA, Carlesso N. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL [Internet]. Leukemia. 2020 ; 34( 5): 1241-1252.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41375-019-0653-zVancouver
Rodriguez S, Abundis C, Boccalatte F, Mehrotra P, Chiang MY, Yui MA, Wang L, Zhang H, Zollman A, Bonfim-Silva R, Kloetgen A, Palmer J, Sandusky G, Wunderlich M, Kaplan MH, Mulloy JC, Marcucci G, Aifantis I, Cardoso AA, Carlesso N. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL [Internet]. Leukemia. 2020 ; 34( 5): 1241-1252.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41375-019-0653-z
